Effect of a μ-selective opioid antagonist on CCK-8-induced changes in thermoregulation in the rat

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 1, 1998, Pages 261-264

  Ghosh, Suchandra ^a   Handler, Cynthia M ^a   Geller, Ellen B ^a   Adler, Martin W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain temperature; Cholecystokinin; Mu opioid antagonist; Oxygen consumption; Thermoregulation

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; PHE CYS TYR TRP ARG THR PEN THR NH2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; HEAT EXCHANGE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; THERMOREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BODY TEMPERATURE REGULATION; CALORIMETRY; INJECTIONS, INTRAVENTRICULAR; MALE; NARCOTIC ANTAGONISTS; OXYGEN CONSUMPTION; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SINCALIDE;

ANIMALIA;

EID: 0031963311     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00416-4     Document Type: Article

References (27)

1. Adler M. W., Geller E. B., Rosow C. E., Cochin J. The opioid system and temperature regulation. Annu. Rev. Pharmacol. Toxicol. 28:1988;429-449.
2. Beinfeld M. C. Cholecystokinin in the central nervous system. A minireview Neuropeptides. 3:1983;411-427.
3. Blatteis C. M. Hypothalamic substances in the control of body temperature. General characteristics Fed. Proc. 40:1981;2735-2740.
4. Bligh J. The central neurology of mammalian thermoregulation. Neuroscience. 4:1979;1213-1235.
5. Burks T. F. Opioids and opioid receptors in thermoregulation. Schönbaum E., Lomax P. Thermoregulation. Pathology, pharmacology and therapy:1991;489-508 Pergamon, New York.
6. Clark W. G. Effects of opioid peptides on thermoregulation. Fed. Proc. 40:1981;2754-2759.
7. Clark W. G., Lipton J. M. Changes in body temperature after administration of amino acids, peptides, dopamine, neuroleptics and related agents. II Neurosci. Biobehav. Rev. 9:1985;299-371.
8. Faris P. L., Komisaruk B. R., Watkins L. R., Mayer D. J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
9. Geller E. B., Adler M. W. Drugs of abuse and body temperature. Adler M. W., Cowan A. Testing and evaluation of drugs of abuse. 1990;101-119 Wiley-Liss, New York.
10. Geller E. B., Rowan C. H., Adler M. W. Body temperature effects of opioids in rats. Intracerebroventricular administration Pharmacol. Biochem. Behav. 24:1986;1761-1765.
11. Ghosh S., Geller E. B., Adler M. W. Interaction of cholecystokinin and somatostatin with a selective mu opioid agonist and mu and kappa antagonists in thermoregulation. Brain Res. 745:1997;152-157.
12. Han J.-S., Ding X.-Z., Fan S.-G. Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates? Neuropeptides. 5:1985;399-402.
13. Handler C. M., Bradley E. A., Geller E. B., Adler M. W. A study of the physiological mechanisms contributing to neurotensin-induced hypothermia. Life Sci. 54:1993;95-100.
14. Handler C. M., Geller E. B., Adler M. W. Effect of μ-, κ-, and δ-selective opioid agonists on thermoregulation in the rat. Pharmacol. Biochem. Behav. 43:1992;1209-1216.
15. Kandasamy S. B., Williams B. A. Cholecystokinin-octapeptide-induced hyperthermia in guinea-pigs. Experientia. 39:1983;1282-1284.
16. Kapás L., Benedek G., Penke B. Cholecystokinin interferes with the thermoregulatory effect of exogenous and endogenous opioids. Neuropeptides. 14:1989;85-92.
17. Kapás L., Obál F. Jr., Penke B., Obál F. Cholecystokinin-octapeptide-induced hypothermia in rats. Dose-effect and structure-effect relationships, effect of ambient temperature, pharmacological interactions and tolerance Neuropharmacology. 26:1987;131-137.
18. Legido A., Adler M. W., Karkanias C., Geller E. B., Bradley E., Greenstein J. I., Grover W. D. Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors. Neuropeptides. 28:1995;107-113.
19. Miceli M. O., van der Kooy D., Post C. A., Della-Fera M. A., Baile C. A. Differential distributions of cholecystokinin in hamster and rat forebrain. Brain Res. 402:1987;318-330.
20. Romanovsky A. A., Shido O., Ungar A. L., Blatteis C. M. Peripheral naloxone attenuates lipopolysaccharide fever in guinea pigs by an action outside the blood-brain barrier. Am. J. Physiol. 266:1994;R1824-31.
21. Shian L. R., Lin M. T. Effects of cholecystokinin octapeptide on thermoregulatory responses and hypothalamic neuronal activity in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 328:1985;363-367.
22. Spencer R. L., Hruby V. J., Burks T. F. Alteration of thermoregulatory set point with opioid agonists. J. Pharmacol. Exp. Ther. 252:1990;696-705.
23. Szelényi Z., Barthó L., Székely M., Romanovsky A. A. Cholecystokinin octapeptide (CCK-8) injected into a cerebral ventricle induces a fever-like thermoregulatory response mediated by type B CCK-receptors in the rat. Brain Res. 638:1994;69-77.
24. Székely M., Szelényi Z., Balasko M. Cholecystokinin participates in the mediation of fever. Pflugers Arch. Eur. J. Physiol. 428:1994;671-673.
25. Xin L., Geller E. B., Sterling G. H., McCafferty M. R., Adler M. W. Interactions between cholecystokinin (CCK) and selective μ and κ opioid receptor agonists in the periaqueductal gray (PAG) of the rat. NIDA Res. Monogr. 153:1995;117.
26. Zetler G. Cholecystokinin octapeptide, caerulein and caerulein analogues. Effects on thermoregulation in the mouse Neuropharmacology. 21:1982;795-801.
27. Zwil A. S., Lynch T. J., Martinez R. P., Geller E. B., Adler M. W. Calorimetric analysis of ICV morphine in the rat. Harris L. S. Problems of drug dependence 1987, NIDA Research Monograph #81. 1988;285 U.S. Government Printing Office, Washington, DC.